This is the first time a generic glucagon-like peptide-1 receptor agonist (GLP-1RA) medication has been approved for weight loss in the US
Following incubating with 2 M fura-2 AM (DOJINDO, Kumamoto, Japan) for 30 min at 37 C, the cells were mounted in chamber and superfused at 1.3 ml min 1 at 30 C with HKRB containing 5.6 mM glucose
doi:10.1210/mend.15.5.0641
Important safety considerations include: Pancreatitis : Seek urgent medical attention for severe, persistent abdominal pain (which may radiate to the back), with or without vomiting Gallbladder disease : Report right upper quadrant pain, fever, or yellowing of the skin/eyes Diabetic retinopathy complications : Be aware that rapid improvement in blood glucose can temporarily worsen retinopathy
Abelovska notes that rapid weight loss is associated with an increased risk of: If youre looking for a way to lose weight, its best to consider the pros and cons before choosing medications